FIELD: medicine, virology, pharmaceutical industry. SUBSTANCE: preparation comprises remantadine fixed on polymer and 20-60% sugar syrup or sorbite syrup. The preparation is prepared by mixing remantadine, sodium alginate and indicated syrup in the following ratio of parent components, wt.-%: rematadine, 0.05-5.0; sodium alginate, 0.05-5.0; 20-60% sugar syrup or sorbite syrup, the balance. Preferable ratio remantadine to sodium alginate is 1:1. EFFECT: high bioavailability and effectiveness of preparation. 2 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL PREPARATION | 1994 |
|
RU2071323C1 |
| AGENT FOR INFLUENZA TREATMENT | 2003 |
|
RU2229877C1 |
| DRUG FOR RESPIRATORY INFECTIOUS DISEASES GLUCAFERON | 2011 |
|
RU2450812C1 |
| ANTIVIRAL AGENT FOR PREVENTING AND TREATING TICK-BORNE ENCEPHALITIS | 2010 |
|
RU2444363C2 |
| METHOD AND AGENT ACTIVATING IRF-3 FOR TREATING AND PREVENTING DISEASES CAUSED BY (+) RNA CONTAINING VIRUSES | 2012 |
|
RU2518314C2 |
| SOLID DOSAGED FORM FOR ORAL USING SHOWING ANTIVIRAL ACTIVITY (VARIANTS) | 1995 |
|
RU2115415C1 |
| AGENT FOR ENHANCING BODY RESISTANCE AGAINST VIRAL AND VIRUS-INDUCED DISEASES | 2005 |
|
RU2319497C2 |
| NEW FORMULATIONS OF 2-(IMIDAZOLE-4-YL)-ETHANAMIDE PENTANEDIOIC-1,5 ACID FOR THE TREATMENT AND PREVENTION OF VIRAL DISEASES | 2020 |
|
RU2782532C2 |
| NOVEL 2-(IMIDAZOL-4-YL)-ETHANAMIDE PENTANEDIOIC-1,5 ACID COMPOSITIONS FOR TREATING AND PREVENTING VIRAL DISEASES | 2020 |
|
RU2746692C1 |
| NOVEL FORMULATIONS OF 2-(IMIDAZOL-4-YL)-ETHANAMIDE OF PENTANEDIOIC ACID FOR TREATMENT AND PREVENTION OF VIRAL DISEASES | 2020 |
|
RU2791902C2 |
